Moreover, recent clinical studies suggested that SERPINA1 is also a promising anti-inflammatory therapeutic to treat obesity-associated insulin resistance, cystic fibrosis, and COVID-19.44 The gene discussed is SERPINA1; the disease is Insulin resistance.